Marisa Wexler is a senior science writer for Myeloma Research News with an MS in cellular and molecular pathology. She covers the latest news and information on a variety of myeloma topics.| Myeloma Research News
The CAR T-cell therapy Carvykti controlled disease activity in most myeloma patients who hadn't fully responded to standard cell transplant.| Myeloma Research News